Funder: METAvivor
Due Dates: February 5, 2025 (Portal Opens) | March 11, 2025 (Letter of Intent Due)
Funding Amounts: $450,000 total over 3 years for established investigators
Summary: Supports translational research to advance the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer.